QNC Powerpoint'QNC’s market strategy will be to license its’ patented and proven technology to leading manufacturers and OEMs in the Healthcare industry. We plan to sell directly or work with agents and integrators according to target market dynamics. In this Phase 2 we plan to:
1. Establish a profitable pricing structure and go-to-market model.
2. Establish advantageous legal contracts, licensing agreements, maintain and grow current IP assets and investments.
3. Identify and engage in Beta program talks and agreements with potential clients and partners.'
"By providing the smallest, most reliable, scalable, high speed and most cost effective QRNG, QNC will be in a leading pole position to license and supply the upcoming increase demand for affordable solutions, which are well designed to secure the critical healthcare communication between patient connected devices and the healthcare services that ensure their well being.
"Moving forward, QNC will mandate a selected private sector firm to speed up this next R&D phase, which is currently scheduled to begin at the end of October 2020"
https://www.quantumnumberscorp.com/wp-content/uploads/2020/10/QNC-Investor_Opportunity_2020.pdf